Pitie Salpetriere Hospital — Clinical Trial Site

13 Registered trials

4 Currently recruiting

Organisation

Pitie Salpetriere Hospital

Location

Paris Cedex 13, France

Identifier

ORG-100023261

Address

47 Boulevard De L Hopital, 75651, France

Departments

Department of Rheumatology
Hématologie
Hematology
Hépato-gastroentérologie
hepatogastroenterologie
n/a
NA
Neurologie
Service d'Hematologie Clinique
Service des urgences cérébro-vasculaires

Clinical trials at this site (13)

Search interface

A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised

2022-501644-15-00 Mild Cognitive Impairment due to Alzheimer's Disease Al 4
Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3) Recruiting

2022-500587-35-01 Stroke 5 2023-07-06
Efficacy of a sequential treatment strategy in Rheumatoid Arthritis. Recruiting

2022-500234-29-00 Rheumatoid Arthritis 5 2022-11-28
TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b… Recruiting

2022-500643-20-00 Patients with locally advanced, metastatic or unresecta 4 2022-09-27
CPX-351 versus intensive chemotherapy in patients with de novo intermediate or adverse risk AML stratified by genomics Recruiting

2022-500295-60-00 Acute Myeloid Leukemia 4 2022-09-15
A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzhe… Ended

2022-501644-15-01 Mild Cognitive Impairment due to Alzheimer's Disease Al 4 2023-09-28
Phase 1b study investigating the association of NP137 with Atezolizumab-Bevacizumab combination in first line in unresectable hepatocellular… Ended

2022-500903-38-00 unresectable hepatocellular carcinoma 3 2023-02-09
A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell … Ended

2022-501259-10-00 Relapsed/Refractory Waldenstrom Macroglobulinemia (WM) 4 2023-04-14
A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell … Ended

2022-501260-18-00 Relapsed/refractory Richter Transformation (RT) 4 2023-04-14
A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell Malignancie… Ended

2022-501261-46-00 Relapsed/Refractory Burkitt Lymphoma (BL) 4 2023-04-14
A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell … Ended

2022-501262-21-00 Relapsed/Refractory Hairy Cell Leukemia 4 2023-04-14
Ezurpimtrostat autophagy inhibitor in association with Atezolizumab-Bevacizumab in first line treatment of unresectable hepatocellular carci… Ended

2022-502078-17-00 unresectable hepatocellular carcinoma 4 2022-12-15
Exploratory study evaluating the relevance of [68Ga]Ga-PentixaFor for initial staging and detection of minimal residual disease in multiple … Ended

2022-500339-35-01 Multiple Myeloma 4